AJANTA PHARMA LTD. | Scrip Code : 532331 | Quarter ending :December 2017 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | Yes | Whether any shares held by promoters are pledge or otherwise encumbered? | Yes | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 10 | 6,22,29,759 | 6,22,29,759 | 70.70 | 6,22,29,759 | 70.70 | | 0.00 | 62,60,000 | 10.06 | 6,22,29,759 | - | - | - | (B) Public | 35,220 | 2,57,84,741 | 2,57,84,741 | 29.30 | 2,57,84,741 | 29.30 | 9,500 | 0.04 | | 0.00 | 2,54,12,173 | - | - | - | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | 0.00 | | 0.00 | | - | - | - | Grand Total | 35,230 | 8,80,14,500 | 8,80,14,500 | 100.00 | 8,80,14,500 | 100.00 | 9,500 | 0.01 | 62,60,000 | 7.11 | 8,76,41,932 | - | - | - |
| Note:C=C1+C2 Grand Total=A+B+C
|